1 MAY 2020 - The National Pharmaceutical Services Association (NPSA) – the peak body representing Australia’s CSO wholesalers – has reported further easing in demand for medicines, allowing replenishment of stock and improvement across the supply chain as a whole. While there remain shortages of some products and concerns about import freight … [Read more...]
NPSA statement on equitable medicine supply during COVID-19
22 APRIL 2020 - The supply chain has been experiencing extraordinary demand and pressure due to COVID-19 and all stakeholders in the industry are working to address these issues. There are shortages of certain medicines and fluctuations in supply which are being constructively managed. It is vital to understand that any supply or medicine … [Read more...]
NPSA welcomes ACCC interim authorisation on medicine supply
MEDIA RELEASE 31 MARCH 2020 - The National Pharmaceutical Services Association (NPSA) has welcomed interim authorisation from the ACCC that will allow further proactive measures to support the continuous, fair and equitable supply of medicines across Australia in response to COVID-19. NPSA, a peak industry group, applied for authorisation on … [Read more...]
NPSA Statement on COVID-19 update
MEDIA RELEASE 19 MARCH 2020 - The National Pharmaceutical Services Association (NPSA) has welcomed latest government moves to manage equitable access to medicines for all Australians with limits on dispensing of certain prescription products and sales of some OTC medicines. NPSA Chair Mark Hooper said: “We have been in close consultation with … [Read more...]
Medicine supply during COVID-19 emergency
MEDIA RELEASE 16TH MARCH 2020 - Members of the National Pharmaceutical Services Association (NPSA) have taken proactive measures in consultation with Government and the CSO Agency to help manage demand for medicines due to the COVID-19 emergency. With special approval from the government agency, measures were put in place last week to limit … [Read more...]